Categories: HealthcareNews

BUDS Technology Inc. Announces Name Change of Virtual Medical Assistant from “Nurse Daisy” to “AKSSI” and Expansion into Senior Living Market

ROSWELL, Ga., May 15, 2025 /PRNewswire/ — BUDS Technology Inc., a leader in AI-powered healthcare solutions, is proud to announce the rebranding of its flagship virtual medical assistant application. Effective immediately, the product formerly known as Nurse Daisy will now operate under the new name AKSSI (pronounced “AX-ee”). 

This name change reflects the company’s continued commitment to innovation and clarity in the digital healthcare space. The rebrand aligns with the application’s expanded functionality, advanced artificial intelligence capabilities, and modernized user experience, while also avoiding confusion with similar-sounding names in the marketplace. 

AKSSI delivers the same real-time documentation support, intelligent workflow automation, and seamless virtual assistance for healthcare providers. Designed to reduce clinician burnout and improve operational efficiency, AKSSI has become a trusted solution across a growing number of medical settings. 

In tandem with the rebrand, BUDS Technology Inc. is also announcing its strategic expansion into the senior living and long-term care markets. This move responds to the urgent need for smarter documentation and staffing support in assisted living communities. The AKSSI platform is now available to hospice agencies and senior living communities across the United States. 

For more information, visit www.akssi.com or contact sales@budstechnology.com
Follow BUDS Technology on LinkedIn for ongoing updates. 

Media Contact:
Anna Boisse
Buds Technology Inc.
sales@budstechnology.com
www.budstechnology.com

View original content:https://www.prnewswire.com/news-releases/buds-technology-inc-announces-name-change-of-virtual-medical-assistant-from-nurse-daisy-to-akssi-and-expansion-into-senior-living-market-302456836.html

SOURCE BUDS Technology

Staff

Recent Posts

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

10 hours ago

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…

13 hours ago

Nutri Derma Guard Skin Tag Remover Ingredients Investigated: 2026 Analysis Examines Formulation And Consumer Disclosures

Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…

13 hours ago

SleepZee Mouth Guard Legitimacy Examined: 2026 Consumer Analysis Investigates Anti-Snoring Device Claims and Company Transparency

Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…

13 hours ago